SPOTLIGHT -
Dr. Voltz: What I wish I knew before entering optometry
Kelly Voltz, OD, FAAO, FSLS, shares what she wishes she knew before entering optometry.
Apellis receives FDA acceptance, priority review of NDA for GA treatment
If approved, pegcetacoplan—an investigational, targeted C3 therapy—will be the first-ever treatment for GA.
AOA launches Screen Time Alliance, partnership for Eye Deserve More campaign
The first-of-its-kind alliance and latest phase of AOA's national public awareness campaign focuses on the effects of extended time on digital devices and its impact on eye health.
AAO launches search for new CEO; appoints interim CEO
Current CFO Richard Jones named as interim CEO throughout the search.
Study: Children with myopia more likely to have depression, anxiety
A recent study by Orbis International reports that children with myopia experienced significantly higher levels of depression and anxiety than their peers without vision impairment.
New 2-year data supports faricimab-svoa for treatment of wet AMD
Presented during the 2022 ASRS meeting, results find that over 60% of participants could be treated every 4 months at 2 years—an increase from 45% at year 1.
Study confirms supplements slow AMD progression
A decade after the conclusion of the NIH-funded AREDS2 study, researchers found that the AREDS2 formula also reduces the risk of lung cancer.
Bausch + Lomb, Novaliq submit NDA for NOV03 to treat DED associated with MGD
Drug submission of the first water-free therapy took place at the end of June, according to the companies.
Novartis acquires Kedalion Therapeutics and its ocular delivery platform
The company intends to develop the AcuStream technology for potential use with its current and future front-of-eye therapies, which may include lifitegrast ophthalmic solution for the treatment of dry eye disease.
In-eye testing begins for first AR-based, smart contact lens
Mojo Vision's CEO Drew Perkins announced last week that he became the first, and currently only, person to wear the latest prototype of Mojo Lens, an augmented reality-based contact lens.
Advanced multi-purpose solution for soft re-usable contact lenses
Bausch + Lomb's Bill Reindel, OD, speaks on highlights from his lecture titled “Evaluation of an Advanced Multi-Purpose Solution for Soft Re-Usable Contact Lenses."
Role of paraoptometrics in ocular surgery
During AOA 2022, Cecelia Koetting, OD, FAAO, shares highlights from her presentation titled "Ocular Surgeries and the Role of the Paraoptometric."
Alzheimer's disease and optometry: diagnosis, prevention, management
Stuart Richer, OD, PhD, provides an overview of his AOA 2022 presentation titled, "Alzheimer's disease: diagnostic criteria, prevention, and lifestyle management."
How to financially prepare for post-graduation
During AOA 2022, Mile Brujic, OD, FAAO, shares his advice and best practices for new optometry school grads on how to be financially smart.
Johnson & Johnson Vision on track for multinational launch of newest contact lenses
The company has received the all-clear for a multinational market launch of Acuvue Oasys Max 1-Day and Acuvue Oasys Max 1-Day multifocal contact lenses.
Bausch + Lomb launches customizable soft contact lenses in US
The Revive custom soft contact lenses are designed with non-ionic material that allows for daily wear for up to 3 months.
Q&A: Streamlining the dry eye patient process in practice
Maria Sampalis, OD, discusses streamlining the dry eye process in her practice for optimum efficiency.
Contact lens regimen crucial in removing coronavirus traces
A new study has found that having a contact lens regimen makes a difference when removing coronavirus particles, as well as the type of lens care solution that is used.
Dr. Anshel offers guidelines on eyestrain management in new book
Jeffrey Anshel, OD, FAAO, offers a sneak peek of his latest book titled "What you must know about eyestrain."
Q&A: Setting up a dry eye patient schedule
Maria Sampalis, OD, shares what a typical schedule for dry eye patients looks like on a daily and weekly basis at her practice.
Alcon partners with NFL star Cooper Kupp on eye allergy campaign
The new partnership supports Alcon's Pataday Once Daily Relief Extra Strength eye drops as treatment for eye allergies.
Bausch + Lomb launches latest Biotrue contact lens solution in US
New solution contains 25% more moisture, company says.
FDA approves brolucizumab-dbll 6 mg for DME treatment
This is the second FDA-approved indication for BEOVU; it was initially approved in 2019 for the treatment of wet AMD.
Apellis submits NDA to FDA for geographic atrophy treatment
A decision by the FDA is expected in August 2022.
Q&A: How to make your dry eye practice unique
Maria Sampalis, OD, shares how her practices is able to set itself apart from others within the dry eye field.
Dr. Dunbar: What I wish I knew before entering optometry
Mark T. Dunbar, OD, FAAO, shares what he wished he knew before entering the optometric profession.
Battery-free, smart contact lens delivers glaucoma drugs
Investigators from the Sun Yay-Sen University in Guangzhou have created a theranostic device that targets sensing rising fluid pressures within the eye to automatically deliver medication for a glaucoma patient.
Aerie doses first patient in phase 3 DED treatment study
The COMET-2 study is the first of three studies in the AR-15512 phase 3 registration program, with topline results expected by the second half of 2023.
Q&A: Pandemic's effect on dry eye patient numbers
Maria Sampalis, OD, continues her dry eye discussion what factors she considers when diagnosing and treating patients.
Dr. Fuller: What I wish I knew before entering optometry
Daniel G. Fuller, OD, FAAO Dipl., FSLS, shares what he wish he knew before entering the field.